BUND FINANCE

BUND FINANCE › Stocks › LH

Labcorp Holdings Inc. (LH)

NYSE · Stock price, chart and technical analysis

US$370.78+2.54 (+0.69%)

Data from Financial Modeling Prep · Nov 18, 2026, 4:00 PM New York time · may be delayed

Open the live chartSee Technicals⏱ Analyze entryQuarterly earnings📅 See in calendar💬 Explain this move⇄ ComparePractice in the Simulator

Key stats

Previous closeUS$368.24
OpenUS$364.97
Day rangeUS$363.00 – US$371.28
52-week rangeUS$245.00 – US$375.10
Market capUS$30.11B
Volume689,929
50-day averageUS$331.42
200-day averageUS$293.40
Beta0.84
Last dividend per shareUS$2.88

Quick technical read

This describes price action; it is not a recommendation. The app also calculates RSI, MACD, the entry setup and 30+ indicators. How we calculate it

Fundamentals Annual

Fiscal year20212022202320242025
RevenueUS$13.1BUS$11.9BUS$12.2BUS$13.0BUS$14.0B
Net incomeUS$2.4BUS$1.3BUS$418.0MUS$746.0MUS$876.5M
EPS (diluted)24.3813.964.778.8410.46
Gross margin38.0%31.3%27.7%27.9%28.8%
Operating margin23.2%12.1%6.0%8.4%9.9%
Net margin18.1%10.8%3.4%5.7%6.3%
Free cash flowUS$2.6BUS$1.5BUS$874.1MUS$1.1BUS$1.2B
Total debtUS$6.3BUS$6.2BUS$6.0BUS$7.3BUS$6.5B
CashUS$1.5BUS$320.6MUS$536.8MUS$1.5BUS$532.3M

Compound annual growth: revenue 1.5% · net income -22.1% (4 years).

Valuation: today, its history and its sector

Today5-year averageSector median (Healthcare)
P/E30.4x24.5x27.1x
EV / EBITDA17.0x13.4x16.5x
Operating margin11.1%—3.6%
Net margin6.9%—-0.0%
Debt / equity1.14—0.58

Source: annual financial statements from Financial Modeling Prep. “Today” uses the current price and the last 4 quarters. The sector median uses U.S. companies above US$300M market cap. A multiple above or below its history or sector is not a recommendation.

About Labcorp Holdings Inc.

SectorHealthcare
IndustryMedical - Diagnostics & Research
CountryUS
CEOAdam H. Schechter
Employees71,000
IPO date1990-03-29

Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.

www.labcorp.com

Other stocks on BUND FINANCE

Not financial advice. BUND FINANCE publishes general information for educational purposes. Investing involves risk, including loss of capital. Legal notice